Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 30 Records) |
Query Trace: Head and Neck Neoplasms and TP53[original query] |
---|
Haplotype structure of TP53 locus in Indian population and possible association with head and neck cancer. Annals of human genetics 2003 Jan 67 (Pt 1): 26-34. Mitra S, Chatterjee S, Panda C K, Chaudhuri K, Ray K, Bhattacharyya N P, Sengupta A, Roychoudhury |
Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2004 Apr 10 (8): 2594-9. Blons H, Gad S, Zinzindohoué F, Manière I, Beauregard J, Tregouet D, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P |
Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas. Cancer genetics and cytogenetics 2004 Apr 150 (1): 44-9. Cortezzi Sylvia Sanches, Provazzi Paola Jocelan, Sobrinho João S, Mann-Prado José Carlos, Reis Patrícia Maria Pizzo, de Freitas Suzy Elaine Nobre, Filho José Francisco Góis, Fukuyama Erica E, Cordeiro José Antônio, Cury Patrícia Maluf, Maniglia José Vítor, Villa Luísa Lina, Tajara Eloiza Helena, Rahal Pau |
p53 in head and neck cancer: functional consequences and environmental implications of TP53 mutations. Head & neck oncology 2010 Dec 2 (1): 1. Peltonen JK, Helppi HM, Paakko P, Turpeenniemi-Hujanen T, Vahakangas KH |
[Analysis of mutations within the TP53 gene in patients with squamous cell carcinoma of the head and neck]. Otolaryngologia polska. The Polish otolaryngology 0 65 (2): 114-21. Golusinski Pawe?, Lamperska Katarzyna, Pazdrowski Jakub, Golusinski Wojcie |
Allelic expression imbalance of TP53 mutated and polymorphic alleles in head and neck tumors. Omics : a journal of integrative biology 2011 Jun 15 (6): 375-81. Ganci Federica, Conti Salvatore, Fontemaggi Giulia, Manciocco Valentina, Donzelli Sara, Covello Renato, Muti Paola, Strano Sabrina, Blandino Giovanni, Spriano Giusep |
Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Jan 18 (1): 196-206. Azad Abul Kalam, Bairati Isabelle, Samson Elodie, Cheng Dangxiao, Mirshams Maryam, Qiu Xin, Savas Sevtap, Waldron John, Wang Changshu, Goldstein David, Xu Wei, Meyer Francois, Liu Geoffr |
Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 May 19 (9): 2528-40. Roh Jong-Lyel, Wang Xin Victoria, Manola Judith, Sidransky David, Forastiere Arlene A, Koch Wayne |
MDM2 and TP53 Polymorphisms as Predictive Markers for Head and Neck Cancer in Northeast Indian Population: Effect of Gene-Gene and Gene-Environment Interactions. Asian Pacific journal of cancer prevention : APJCP 2015 16 (14): 5767-72. Bhowmik Aditi, Das Sambuddha, Bhattacharjee Abhinandan, Choudhury Biswadeep, Naiding Momota, Deka Sujata, Ghosh Sankar Kumar, Choudhury Yashm |
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer. International journal of cancer. Journal international du cancer 2015 Jun . Wichmann Gunnar, Rosolowski Maciej, Krohn Knut, Kreuz Markus, Boehm Andreas, Reiche Anett, Scharrer Ulrike, Halama Dirk, Bertolini Julia, Bauer Ulrike, Holzinger Dana, Pawlita Michael, Hess Jochen, Engel Christoph, Hasenclever Dirk, Scholz Markus, Ahnert Peter, Kirsten Holger, Hemprich Alexander, Wittekind Christian, Herbarth Olf, Horn Friedemann, Dietz Andreas, Loeffler Markus, |
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. Cancer research 2015 Apr 75 (7): 1205-15. Osman Abdullah A, Neskey David M, Katsonis Panagiotis, Patel Ameeta A, Ward Alexandra M, Hsu Teng-Kuei, Hicks Stephanie C, McDonald Thomas O, Ow Thomas J, Alves Marcus Ortega, Pickering Curtis R, Skinner Heath D, Zhao Mei, Sturgis Eric M, Kies Merrill S, El-Naggar Adel, Perrone Federica, Licitra Lisa, Bossi Paolo, Kimmel Marek, Frederick Mitchell J, Lichtarge Olivier, Myers Jeffrey |
Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer. Oncotarget 2016 Sep 7 (38): 61575-61586. van Ginkel Joost H, de Leng Wendy W J, de Bree Remco, van Es Robert J J, Willems Stefan |
Correlation of TP53 and MDM2 genotypes and clinical outcome in platinum-treated head and neck cancer patients with more than 10 years' follow-up. The International journal of biological markers 2016 Feb 0. Vivenza Daniela, Monteverde Martino, Lattanzio Laura, Tonissi Federica, Astesana Valentina, Denaro Nerina, Comino Alberto, Russi Elvio, Lo Nigro Cristiana, Merlano Mar |
Detection of nasopharyngeal carcinoma susceptibility with single nucleotide polymorphism analysis using next-generation sequencing technology. Oncotarget 2017 (32): 52708-52723. Wu Mu-Yun, Huang Shu-Jing, Yang Fan, Qin Xin-Tian, Liu Dong, Ding Ying, Yang Shu, Wang Xi-Che |
Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer. Oral oncology 2017 Apr 67 70-76. Borchiellini D, Etienne-Grimaldi M C, Bensadoun R J, Benezery K, Dassonville O, Poissonnet G, Llorca L, Ebran N, Formento P, Château Y, Thariat J, Milano |
Assessment of DNA repair susceptibility genes identified by whole exome sequencing in head and neck cancer. DNA repair 2018 5 66-67 50-63. Das Raima, Kundu Sharbadeb, Laskar Shaheen, Choudhury Yashmin, Ghosh Sankar Kum |
Clinical Significance of CUB and Sushi Multiple Domains 1 Inactivation in Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 2018 Dec 19 (12): . Jung Ah Ra, Eun Young-Gyu, Lee Young Chan, Noh Joo Kyung, Kwon Kee Hw |
Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population. Cancers 2019 Apr 11 (4): . Fernández-Mateos Javier, Seijas-Tamayo Raquel, Adansa Klain Juan Carlos, Pastor Borgoñón Miguel, Pérez-Ruiz Elisabeth, Mesía Ricard, Del Barco Elvira, Salvador Coloma Carmen, Rueda Dominguez Antonio, Caballero Daroqui Javier, Fernández Ruiz Encarnación, Ocana Alberto, González-Sarmiento Rogelio, Cruz-Hernández Juan Jes |
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival. Cancers of the head & neck 2019 4 5. Mundi Neil, Prokopec Stephenie D, Ghasemi Farhad, Warner Andrew, Patel Krupal, MacNeil Danielle, Howlett Christopher, Stecho William, Plantinga Paul, Pinto Nicole, Ruicci Kara M, Khan Mohammed Imran, Han Myung Woul, Yoo John, Fung Kevin, Sahovaler Axel, Palma David A, Winquist Eric, Mymryk Joe S, Barrett John W, Boutros Paul C, Nichols Anthony |
Tumor microenvironment characterization in head and neck cancer identifies prognostic and immunotherapeutically relevant gene signatures. Scientific reports 2020 Jul 10 (1): 11163. Huo Mengqi, Zhang Ying, Chen Zhong, Zhang Suxin, Bao Yang, Li Tian |
Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer. Medical science monitor : international medical journal of experimental and clinical research 2020 6 26 e923208. Ge Hua, Yan Yan, Yan Maozhao, Guo Lingfei, Mao K |
Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer. Oral oncology 2021 Jun 119 105369. Xu Jiali, Wang Rong, Wang Tongshan, Wang Tingting, Gu Dejian, He Yuange, Shu Yongqian, Chen Rongrong, Liu Lian |
Whole genome duplication in oral squamous cell carcinoma in patients younger than 50?years: implications for prognosis and adverse clinicopathological factors. Genes, chromosomes & cancer 2022 Jun . Satgunaseelan Laveniya, Strbenac Dario, Willet Cali, Chew Tracy, Sadsad Rosemarie, Wykes James, Low Tsu-Hui Hubert, Cooper Wendy A, Lee C Soon, Palme Carsten E, Yang Jean Y H, Clark Jonathan R, Gupta Ru |
Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234. Advances in radiation oncology 2022 11 7 (6): 100989. Michikawa Chieko, Torres-Saavedra Pedro A, Silver Natalie L, Harari Paul M, Kies Merrill S, Rosenthal David I, Le Quynh-Thu, Jordan Richard C, Duose Dzifa Y, Mallampati Saradhi, Trivedi Sanchit, Luthra Rajyalakshmi, Wistuba Ignacio I, Osman Abdullah A, Lichtarge Olivier, Foote Robert L, Parvathaneni Upendra, Hayes D Neil, Pickering Curtis R, Myers Jeffrey |
Comprehensive Genome profile testing in head and neck cancer. Auris, nasus, larynx 2023 5 . Masashi Kuroki, Ryota Iinuma, Hiroshi Okuda, Kosuke Terazawa, Hirofumi Shibata, Ken-Ichi Mori, Toshimitsu Ohashi, Akitaka Makiyama, Manabu Futamura, Tatsuhiko Miyazaki, Yukio Horikawa, Takenori Oga |
A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma---A systematic review. Mutation research. Reviews in mutation research 2023 11 108477. Xiaomin Huang, Paul Leo, Lee Jones, Pascal Hg Duijf, Gunter Hartel, Lizbeth Kenny, Sarju Vasani, Chamindie Punyadee |
Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay. Current oncology (Toronto, Ont.) 2023 10 30 (10): 8902-8915. Michael I Koukourakis, Erasmia Xanthopoulou, Ioannis M Koukourakis, Sotirios P Fortis, Nikolaos Kesesidis, Christos Kakouratos, Ioannis Karakasiliotis, Constantin N Baxevan |
Analysis of mutational variations in TP53 tumour suppressor gene among Pakistani head and neck cancer patients. Ecancermedicalscience 2024 7 18 1703. Summera Fatima, Asia Bibi, Sara Samad Qureshi, Suman Kh |
Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer. Oral oncology 2024 6 154 106875. Rebecca Krc, William Mendes, Jason Molitoris, Matthew Ferris, Yang Song, Amol Shetty, Ranee Mehra, John C Papadimitriou, Kyle Hatten, Rodney Taylor, Jeffrey Wolf, Kai Sun, Soren Bentzen, William Regine, Phuoc Tran, Matthew Wit |
Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy. Cancer research and treatment 2024 12 . Eun Joo Kang, Shinwon Hwang, Yun-Gyoo Lee, Jong-Kwon Choi, Seong Hoon Shin, Yoon Hee Choi, Keun-Wook Lee, Hyun Woo Lee, Min Kyoung Kim, Seung Taek Lim, Hwan Jung Yun, Sang-Gon Park, Sangwoo Kim, Sung-Bae Kim, Hye Ryun K |
- Page last reviewed:Feb 1, 2024
- Content source: